Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial.
Lancet. 2019 Dec 21;394(10216):2263-2270. doi: 10.1016/S0140-6736(19)32518-8. Epub 2019 Dec 10.
Lancet. 2019.
PMID: 31836196
Free PMC article.
Clinical Trial.